USPTO serial 90078434
ACRO
Reviewed by CopyMark Law Group
Status 605
- Filing date
- Status date
- Registration date
- —
- Examiner
- CALLERY, TIMOTHY JOHN
- Law office
- GENERIC WEB UPDATE
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ACRO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Paul A. McLean
Paul A. McLean GREENBERG TRAURIG, LLP1900 UNIVERSITY AVENUE, FIFTH FLOOREAST PALO ALTO, CA 94303UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Biological human living tissues, namely, biological human living tissue cultures for medical purposes, biological human living skin tissues intended for subsequent implantation; surgical implants comprised of living tissues; medicines for human purposes, namely, antibiotics and growth factors for use in tissue engineering and regenerative medicine, and cell therapies; preparations to facilitate teething, namely, gels, paste, and putty; medicines for dental purposes, bone cement for surgical purposes; bone cement for orthopaedic purposes; materials for dressings, namely, wound healing material in the nature of hemostatic gel matrix preparations, wound dressing, decellular dermis in the nature of hemostatic gel matrix preparations, and hemostatics for medical purposes in the nature of hemostatic dressings to control bleeding, hemostatic powder, and hemostatic materials in the nature of matrix; grafting gums in the nature of matrix, namely, medicated gum for medical grafting purposes; absorbent wadding for medical purposes; teeth filling materials; medicines for veterinary purposes, namely, antibiotics and growth factors for use in tissue engineering and regenerative medicine, and cell therapy; medical trauma dressing for animals; biological tissue cultures for veterinary purposes; stem cells for veterinary purposes; hygienic eye patches and wound dressings in the nature of wound patches for medical purposes; biological tissue grafts, namely, tissue regeneration membrane for dental, medical, and surgical anti-adhesive use; injectable dermal fillers | ABANDONED | — |
| 010 | Coronary stents; implants comprising natural, non-living materials, namely, implantable nerve scaffolds made of collagen protein for neuron regeneration and neuron repair; blood vessel prostheses; implants consisting of artificial materials, namely, artificial eyes, artificial heart, artificial liver, artificial kidney, artificial pancreas, artificial lung, artificial intestines; intravascular stents; artificial skins for surgical purposes; surgical cornea implants comprised of non-living tissue; artificial skins comprised of non-living tissue for surgical purposes; surgical implants comprised of artificial materials; biodegradable bonefixation implants; medical apparatus, namely, apparatus for aesthetic and surgical uses in the nature of cosmetic apparatus using ultrasound for performing aesthetic skin treatment procedures, phototherapeutic apparatus for medical purposes in the nature of a light-emitting diode light source for medical and aesthetic skin treatments, marking pens for use in surgical procedures; medical instruments, namely, apparatus for aesthetic and surgical uses in the nature of cosmetic apparatus using ultrasound for performing aesthetic skin treatment procedures, phototherapeutic apparatus for medical purposes in the nature of a light-emitting diode light source for medical and aesthetic skin treatments, marking pens for use in surgical procedures; sprayers for cleaning gums and teeth used in dentists' offices during dental procedures; dental instruments for use in augmentation and implants; testing apparatus for medical purposes, namely, apparatus for aesthetic and surgical uses in the nature of immunochemical testing apparatus for medical use, medical diagnostic apparatus for testing DNA and RNA samples, organoleptic diagnostic testing apparatus for medical use; artificial absorbable sutures; suture materials; massage apparatus; suture materials, namely, tapes for skin suture | ABANDONED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 29, 2021 | MAB5 | ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION | — |
| Nov 29, 2021 | ABN5 | ABANDONMENT - AFTER PUBLICATION | — |
| Nov 24, 2021 | EXAR | TEAS EXPRESS ABANDONMENT RECEIVED | — |
| Aug 17, 2021 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Aug 17, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 17, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 28, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 12, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 22, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 22, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 21, 2021 | ALIE | ASSIGNED TO LIE | — |
| Apr 6, 2021 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Mar 10, 2021 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Mar 10, 2021 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Mar 10, 2021 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jan 28, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 27, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 27, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 23, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 23, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 23, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 23, 2020 | LOPR | LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN | — |
| Nov 16, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 13, 2020 | LOPT | LETTER OF PROTEST EVIDENCE FORWARDED | — |
| Aug 28, 2020 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Aug 27, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 31, 2020 | NWAP | NEW APPLICATION ENTERED | — |